Portfolio company
AtaCor Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops extravascular defibrillation leads and deployment systems for cardiac patients to manage heart rhythms without entering the vascular system.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Miracor Medical SA
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
EBR Systems
This company develops leadless endocardial pacing systems for physicians to treat patients requiring cardiac resynchronisation therapy.
Argá Medtech
This company develops non-thermal cardiac ablation systems and proprietary catheters for healthcare providers to treat atrial fibrillation and other cardiac arrhythmias.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
S4 Medical
This company develops an esophageal deviation device to protect patients from thermal injury during cardiac ablation procedures for atrial fibrillation.
Append Medical
The company develops a transcatheter system for left atrial appendage elimination to prevent strokes in patients with atrial fibrillation without leaving permanent metal implants.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
Kardium
This company develops a mapping and pulsed field ablation system used by physicians to treat patients with atrial fibrillation.
